Results 211 to 220 of about 13,265 (250)
Barrett's esophagus and adenocarcinoma [PDF]
European Journal of Cardio-Thoracic Surgery, 1987 Sixty-two cases of Barrett's esophagus were observed among 707 patients with hiatal hernia (8.7%). The symptomatology of this condition is described. An additional 10 adenocarcinomas were associated with a Barrett's esophagus--a carcinoma prevalence of 13.8%.
E. Mensier, Ribet M, F. R. Pruvot
openaire +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Gastroenterology, 2004
Strides have been made in the past year to identify means of decreasing mortality from esophageal adenocarcinoma. This requires a thorough understanding of the risk factor for its development, Barrett esophagus. This article summarizes the most up-to-date and important advancements involving the epidemiology, screening, pathogenesis, surveillance, and ...
John A, Bonino, Prateek, Sharma
openaire +2 more sources
Strides have been made in the past year to identify means of decreasing mortality from esophageal adenocarcinoma. This requires a thorough understanding of the risk factor for its development, Barrett esophagus. This article summarizes the most up-to-date and important advancements involving the epidemiology, screening, pathogenesis, surveillance, and ...
John A, Bonino, Prateek, Sharma
openaire +2 more sources
Barrett’s esophagus and Barrett’s carcinoma
Current Oncology Reports, 2003The alarming rise in the incidence of esophageal adenocarcinomas in the Western world has focused interest on so-called Barrett's esophagus. Barrett's esophagus is characterized by specialized intestinal epithelium replacing the normal squamous epithelium in the distal esophagus and is considered a consequence of long-lasting and severe ...
Hubert J. Stein +2 more
openaire +3 more sources
Biomarkers in Barrett Esophagus
Mayo Clinic Proceedings, 2001Barrett esophagus is a premalignant condition that may progress to adenocarcinoma. The risk of developing cancer has been estimated to be approximately 1 in 250 patient-years of observation; however, there appear to be subsets of patients at much higher risk. Risk stratification has previously been determined by histological identification of dysplasia.
Brian J. Reid +2 more
openaire +3 more sources
Gastritis in Barrett's esophagus
World Journal of Surgery, 1995AbstractDuodenogastric reflux has been implicated in the pathogenesis of complicated Barrett's esophagus and gastric ulceration. A group of 123 Barrett's patients were followed for a mean of 41 months; 9 (7%) developed gastric ulceration (GU). Of the Barrett's patients treated by antireflux surgery, 14% developed GU.
Cedric G. Bremner, Rodney J. Mason
openaire +3 more sources
Biomarkers in Barrett's esophagus
Gastrointestinal Endoscopy Clinics of North America, 2003This article provides a framework for clinicians who are attempting the difficult task of interpreting the Barrett's biomarker literature with the goal of improving care for their patients. Although many articles. including more that 60 proposed biomarkers, have been published on this subject, only a few describe phase 3 and 4 studies that are of ...
Patricia L. Blount +4 more
openaire +3 more sources
Cryotherapy for Barrett’s Esophagus
2018Cryotherapy has been applied in many fields of medicine to treat various diseases. In the last years this technique has been used to treat Barrett esophagus with different systems. Clinical results are at present to be considered slightly more than preliminary but they are promising.
Pagano Nico +2 more
openaire +3 more sources
Endomicroscopy of Barrett’s Esophagus
Gastroenterology Clinics of North America, 2010Endomicroscopy is a remarkable technical advance in gastrointestinal mucosa imaging. In 2003, Kiesslich and colleagues described the first human use of contrast-aided confocal laser endomicroscopy (CLE) as a novel technique for in vivo microscopic imaging of the gastrointestinal mucosa.
openaire +3 more sources
Cryotherapy for Barrett’s Esophagus
Gastrointestinal Endoscopy Clinics of North America, 2017Cryotherapy or cryoablation involves the freezing of tissues to destroy unwanted tissue or to control bleeding. Endoscopic cryotherapy has been developed for gastrointestinal application by through-the-scope noncontact delivery of compressed carbon dioxide gas or liquid nitrogen (cryospray) or contact balloon cryoablation.
openaire +3 more sources